AI-generated illustrations. Individual results vary.
Your GLP-1, TRT and peptide journey, together. 100% free.
Track weight, GLP-1 doses and check-ins in one place.
Keep TRT doses, lab results and the way you feel together.
Track hCG and peptides like tesamorelin: doses, sites, reconstitution and supplies. Explore your data with the AI you choose.
Make it your journeySee an estimated medication level between doses, then compare your progress with clinical trials.
Log a dose, then follow weight, check-ins and side effects alongside it.
Explore the sample
Weekly change
Connect in Profile to import weigh-ins alongside your doses.
We overlay your real weight trajectory on the published trial means, and re-match the arm every time you titrate. Ahead, inside or behind: you always know.
Week 30: you −11.4%, trial arm −13.9%.
Trial curves are smoothed approximations of published means, shown for context only. Not medical advice.
Use optional AI to extract results from a photo, PDF, spreadsheet or text file. Review them before saving, alongside your report's reference ranges.
812 ng/dLIn range
38 pg/mLIn range
52.1 %High
24 ng/mLLow
360 pmol/L
Sample data shown. Not medical advice.
Where it went, what it cost, how far you are from the goal and what your coach thinks about it. Everything the live app learned, redrawn.
Sample intramuscular sites
Tap where you injected. Next time, your last spot glows green so rotating sites is automatic, with IM and SubQ zones for TRT.
Green = your last shotBlue = picked now
“Day 3 after 7.5 mg and your appetite went quiet. That’s the peak doing its job, so eat protein first.”
SCYour coach · Supportive voiceStreaks, first labs and weight milestones unlock real artwork.
$1,284 so far
One tap turns doses, weight, side effects and labs into a clean summary to share.
Sample average weekly change
38 days
Typing in lab results, writing up your progress, guessing when you’ll hit your goal. Turn AI on and Smart Cycle does it for you. Leave it off and every other feature still works.
Weekly, 30-day or whole-journey summaries of your doses, weight, side effects and labs, in plain language and in the coach voice you pick.
AI reviews your weigh-ins to project when you’ll reach your target weight and your next BMI category. If it disagrees with your measured trend, we show the trend instead.
AI can make mistakes and is not medical advice. Content sent with a free Google or Mistral key may be reviewed by that provider to improve its products, so remove names and ID numbers from documents before scanning.
Tell the dose calculator your vial, how much water you mixed in and the dose you want. It shows the exact mark on the syringe, how many doses the vial holds, and warns you when a draw is too small to measure.
Try it with sample numbers
Draw to
10units
on a 1 mL insulin syringe (100 units).
That is a very small draw and hard to measure accurately. Add more water to the vial to make it bigger.
Sample numbers only. Always follow your prescriber's instructions.
Smart Cycle has a built-in MCP server. Connect ChatGPT, Claude, Gemini, Grok, Mistral, Meta’s Muse AI or any other assistant that supports MCP, then just ask. Get a report, compare your progress, or change a record in plain language.
Once connected, the assistant you choose can see the data you allow, and it handles that data under its own company’s privacy terms. AI can make mistakes and is not medical advice.
Every vial, pen and needle you buy is tracked batch by batch. Doses you log draw them down automatically, and anything expiring inside 60 days gets flagged.
Whether you take a weekly GLP-1 shot, follow testosterone replacement therapy, use peptides or just track your weight, Smart Cycle keeps your doses, labs, supplies and progress together.
100% free, with a built-in MCP server so ChatGPT, Claude, Gemini, Grok and Mistral can answer questions and log for you.
Every feature, including AI lab import and weekly reports, costs nothing.
Export everything or delete it in one tap. Leaderboards are opt-in.
English, Português, Español and Français, in kg or lb.
